semaglutide and liver disease 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial Oral semaglutide for weight loss

For a lay audience, think of it as a messenger that wakes up the parts of your brain responsible for sexual motivationit's like turning on a light in a room that's been dim for too long, helping your body respond more naturally to intimate stimuli as you age

Sulfur burps are caused by food fermenting in the stomach because it is sitting there too long

Knowing these predispositions allows your provider to customize your treatment protocol, potentially avoiding unnecessary side effects or premature discontinuation

The dispersion between Novo and Lilly again goes to show the incredible power of competition to dictate stock outcomes: despite Novos excellent financial performance since 2023 (31% growth in 2023, 25% growth in 2024, 48% EBIT margins), the stock has declined because of competition: investors think Eli Lilly is the emerging winner within GLP-1s, given the stronger weight loss profile of tirzepatide (Mounjaro/Zepbound) versus semaglutide (Ozempic/Wegovy), and Lillys more attractive weight loss pipeline assets

Oral Supplements: Capsules and powders often face challenges related to poor bioavailability due to the digestive process, which can degrade glutathione before it reaches the bloodstream

Drug Metab Toxicol 14(3):371377 Ferrazzano L et al (2022) Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges